Early onset of posterior reversible encephalopathy syndrome (PRES) during Cyclosporine-A infusion

Leuk Res. 2011 Oct;35(10):1423-4. doi: 10.1016/j.leukres.2011.02.022. Epub 2011 Mar 11.

Authors

Giovanni F Torelli¹, Fiammetta Natalino, Walter Barberi, Anna P Iori, Chiara Andreoli, Veronica Valle, Caterina Mercanti, Salvatore Perrone, Gianfranco Gualdi, Robin Foà

Affiliation

¹ Bone Marrow Transplant Unit, Division of Hematology, Sapienza University of Rome, Via Benevento 6, 00161 Rome, Italy. torelli@bce.uniroma1.it

PMID: 21397327
DOI: 10.1016/j.leukres.2011.02.022

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Cyclosporine / administration & dosage
Cyclosporine / adverse effects*
Graft vs Host Disease / drug therapy
Graft vs Host Disease / prevention & control
Hematopoietic Stem Cell Transplantation*
Humans
Immunosuppressive Agents / administration & dosage
Immunosuppressive Agents / adverse effects*
Infusions, Intravenous
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
Magnetic Resonance Imaging
Male
Myeloablative Agonists / administration & dosage
Posterior Leukoencephalopathy Syndrome / chemically induced*
Posterior Leukoencephalopathy Syndrome / pathology
Posterior Leukoencephalopathy Syndrome / physiopathology
Transplantation Conditioning*
Transplantation, Homologous

Substances

Immunosuppressive Agents
Myeloablative Agonists
Cyclosporine